Skip to main content
MyCapitol LogoMyCapitol

S 1954 · 119th Congress

Biosimilar Red Tape Elimination Act

This bill aims to reduce regulatory requirements for biosimilar drugs—which are lower-cost copies of expensive biologic medications that work essentially the same way as the original drugs. Right now, when a company wants to bring a biosimilar to market, they have to go through extensive testing and paperwork to pro…

Sponsor
Lee, Mike (R-Utah)
Introduced
2025-06-04
Policy area
Health
Latest action
Placed on Senate Legislative Calendar under General Orders. Calendar No. 521.

Digging through Congress... 🔍